Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML
Clinical trial NCT00430443 · TERMINATED
Trial details
- NCT number
- NCT00430443
- Sponsor
- Callisto Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.